WednesdayNov 11, 2020 11:30 am

Researchers Discover New Cause of Chronic Inflammation in HIV Patients

Data shows that, when compared to persons without HIV, people with HIV have a shorter life expectancy and undergo accelerated aging by up to 10 years. These trends have been linked to prolonged inflammation and may cause the premature onset of diseases associated with age, such as neurocognitive decline, cancers and atherosclerosis. The research findings were in the “Journal of Infectious Diseases,” and its findings highlight the need to create new treatments that target continual inflammation among people with HIV to improve outcomes. When a person is infected with the HIV virus, the virus becomes part of his or her…

Continue Reading

TuesdayNov 10, 2020 1:00 pm

Ethicist Suggests People Should Be Paid to Accept COVID-19 Vaccine

In an opinion piece that was recently accepted for publication in the “Journal of Medical Ethics,” a leading ethicist argues that governments across the world should consider incentivizing individuals to get a coronavirus jab when the vaccine comes on the market. This will help reach the needed level of herd immunity. This may make up at least 80% of the population and will help eliminate the infection. The incentive may be payment in kind or financial. Professor Julian Savulescu, the author of the piece, points out that with the rising worldwide death toll and the extensive economic and health consequences…

Continue Reading

TuesdayNov 10, 2020 11:15 am

Inadequate Nutrition May Be Making Your Child Shorter

A new analysis conducted by the Imperial College London has assessed the weight and height of adolescents and school-aged children around the globe. The study, which was published in “The Lancet” journal, used the data of 65 million children, all aged between 5 and 19, from 193 nations around the world. The analysis discovered a 20 cm difference between children aged 19 in the shortest and tallest nations. This represents a six-year growth gap and an eight-year one for boys and girls respectively. The team of researchers who conducted the study warned that a lack of quality food with regard…

Continue Reading

MondayNov 09, 2020 1:30 pm

Research Shows the Gut Is Pivotal in Protecting Brain from Microbes

The “Nature” journal published a research study last week that highlights the discovery of meninges to be home to plasma cells, which are immune cells that secrete antibodies. These cells are positioned near large blood vessels running in the meninges, which allows them to secrete antibodies that defend the brain’s perimeter. For a long time, scientists couldn’t decipher how the brain remained protected against invading viruses and bacteria. However, a team of researchers led by scientists at the National Institute of Health in the United States and the University of Cambridge in the United Kingdom, have discovered that the specific…

Continue Reading

MondayNov 09, 2020 12:00 pm

Preclinical Research Shows Mothers Can Pass Allergies to Kids

Researchers from Duke-NUS Medical School, KK Women’s and Children’s Hospital and Agency for Science, Technology and Research in Singapore have discovered that mothers can pass their allergies to their offspring while the babies are developing in the womb. This report was published in the “Science” journal last week. The study was conducted in accordance with the NACLAR guidelines. The research team’s discovery demonstrates that immunoglobulin E, the main antibody in charge of triggering allergic reactions, can enter the fetus by crossing the placenta. Once inside the fetus, the antibody hitches itself onto fetal mast cells as observed in mice. Fetal…

Continue Reading

FridayNov 06, 2020 1:37 pm

Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits

POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major company milestone Offering a proprietary automated High Throughput Self-Interaction Chromatography(TM) (“HSC”) Technology Platform, Predictive Oncology (NASDAQ: POAI) provides biomedical and pharmaceutical companies with superior options never before available. A knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, POAI, through its subsidiary Soluble Biotech, delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations. HSC…

Continue Reading

FridayNov 06, 2020 1:30 pm

New Drug May Boost Cancer Patients’ Response to Immunotherapy Treatments

In order to eliminate tumors while strengthening a cancer patient’s immune system, health providers administer cancer immunotherapies to patients. Immunotherapy is revolutionizing the treatment of cancer as many patients respond very well to these treatments, with some actually experiencing a long-lasting remission. However, some types of cancer aren’t as easy to treat with this method, which is why enlarging the effect of this approach remains a high priority. A team of researchers led by Douglas Fearon and Tobias Janowitz, both scientists from Cold Spring Harbor Laboratory, may have found a way to do this. In collaboration with the University of…

Continue Reading

FridayNov 06, 2020 11:45 am

Engineers Develop Heated Face Mask to Kill COVID-19

Face masks, as we have seen, have been effective in filtering out the SARS-CoV-2 virus, thus reducing the risk of a coronavirus infection. A group of scientists from MIT now aim to develop a mask that uses heat to inactivate viruses. These innovative masks will have a built-in, heated copper mesh. When an individual who is wearing the mask breathes in and out, the air flows across the mesh repeatedly, which slows and inactivates any viral particles in the air using high temperatures and the mesh. The researchers state that this mask could be useful for health-care providers as well…

Continue Reading

ThursdayNov 05, 2020 2:23 pm

VistaGen Therapeutics’ (NASDAQ: VTGN) New Generation Phase 3 Drug Candidate for Social Anxiety Disorder Gains Importance Amid FDA Wariness of Benzodiazepines

VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of social anxiety disorder Company sees potential to displace benzodiazepines currently being used to treat multiple anxiety disorders Strategy has gained in importance after U.S. FDA announced in late-September its update requirement for boxed warnings on all benzodiazepines to highlight risks of abuse, misuse, addiction, and physical dependence Benzodiazepine epidemic is as worrisome as the opioid epidemic – 92 million benzodiazepine prescriptions in 2019 according to…

Continue Reading

ThursdayNov 05, 2020 1:00 pm

Research Discovery Suggests Fitness Trackers Could Identify COVID-19 Infections

In a study published last week in “Nature Medicine,” a group of researchers from the Scripps Research Translational Institute discovered that wearable fitness devices may improve public health efforts to control the coronavirus. The data analyzed was collected in the DETECT study, which was launched on March 25. The smartphone app gathers activity tracker and smartwatch data from consenting participants. It also collects the participants’ self-reported symptoms as well as diagnostic test results. Any adult living in the United States can participate in the study; all you have to do is download the MyDataHelps app. The team noted that devices…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050